Novo Ventures Remains Bullish After ‘Very Active’ Year
VC Playbook: An Interview With Naveed Siddiqi
Executive Summary
In this latest installment of VC playbook, In Vivo speaks to Naveed Siddiqi, senior partner at Novo Ventures. He discusses the group’s strategy, the European investment outlook for life sciences and how COVID-19 has permanently shifted perceptions of the biopharma industry.